HL7 - Version 2.7.1

2.1

2.2

2.3

2.3.1

2.4

2.5

2.6

2.7

2.8

2.9

2.7.1

Events

Segments

Msg. Types

Msg. Structs

Data Elements

Tables

Data Structs

Queries

Segment RXA: Pharmacy/Treatment Administration (Informationen zur Medikation)

Seq	Description	German Interpretation	Length	C.LEN	Table	r/o/c	Rep#	Item	Data Structure	Section
1	Give Sub-ID Counter	Art der Substitution		4=		R		00342	NM	4.A.1.1
2	Administration Sub-ID Counter	Laufende Nummer der Verabreichung pro Verordnung (Station)		4=		R		00344	NM	4.A.1.2
3	Date/Time Start of Administration	Verabreichungsbeginn				R		00345	DTM	4.A.1.3
4	Date/Time End of Administration	Verabreichungsende				R		00346	DTM	4.A.1.4
5	Administered Code	Verabreichtes Medikament / Wirkstoff			0292	R		00347	CWE	4.A.1.5
6	Administered Amount	Verabreichte Menge				R		00348	NM	4.A.1.6
7	Administered Units	Maßeinheit			9999	C		00349	CWE	4.A.1.7
8	Administered Dosage Form	Tatsächliche Verabreichungsform			9999	O		00350	CWE	4.A.1.8
9	Administration Notes	Verabreichungshinweise			9999	O	Y	00351	CWE	4.A.1.9
10	Administering Provider	Verabreichende Person / Mitarbeiter				O	Y	00352	XCN	4.A.1.10
11	Administered-at Location	Verabreichungsort (Adresse)				B		00353	LA2	4.A.1.11
12	Administered Per (Time Unit)	Zeiteinheit für Verabreichung		20=		C		00354	ST	4.A.1.12
13	Administered Strength	Verabreichte Wirkstoffmenge				O		01134	NM	4.A.1.13
14	Administered Strength Units	Einheit zu Feld 13			9999	O		01135	CWE	4.A.1.14
15	Substance Lot Number	Chargennummer der Substanz		20=		O	Y	01129	ST	4.A.1.15
16	Substance Expiration Date	Verfalldatum der Substanz				O	Y	01130	DTM	4.A.1.16
17	Substance Manufacturer Name	Hersteller der Substanz			0227	O	Y	01131	CWE	4.A.1.17
18	Substance/Treatment Refusal Reason	Grund fur Ablehnung der Medikation/Behandlung			9999	O	Y	01136	CWE	4.A.1.18
19	Indication	Indikation			9999	O	Y	01123	CWE	4.A.1.19
20	Completion Status	Status der Medikation	2..2		0322	O		01223	ID	4.A.1.20
21	Action Code - RXA	Aktionscode - RXA	1..1		0206	O		01224	ID	4.A.1.21
22	System Entry Date/Time	Erfassungszeitpunkt				O		01225	DTM	4.A.1.22
23	Administered Drug Strength Volume	Lösungsvolumen des verabreichten Wirkstoffs		5=		O		01696	NM	4.A.1.23
24	Administered Drug Strength Volume Units	Maßeinheit des Lösungsvolumens			9999	O		01697	CWE	4.A.1.24
25	Administered Barcode Identifier	Barcode-ID des verabreichten Medikaments			9999	O		01698	CWE	4.A.1.25
26	Pharmacy Order Type	Zusatzinformation Auftragslogistik	1..1		0480	O		01699	ID	4.A.1.26
27	Administer-at	Ort der Verabreichung				O		02264	PL	4.A.1.27
28	Administered-at Address	Adresse der Verabreichung				O		02265	XAD	4.A.1.28

Used within following Message Structures:

CCI_I22 Collaborative Care Information (11.6.2)

CCM_I21 Collaborative Care Message (11.5.1)

CCR_I16 Collaborative Care Referral (11.5.2)

CCU_I20 Collaborative Care Referral (11.5.6)

CQU_I19 Collaborative Care Referral (11.6.1)

CSU_C09 Clinical Trial Message (7.7.2)

PEX_P07 Product Experience Message (7.11.1)

RAS_O17 Pharmacy/Treatment Administration (4.A.11)

RRA_O18 Pharmacy/Treatment Administration Acknowledgment M (4.A.12)

RSP_Z86 Response Grammar: Pharmacy Information Comprehens (5.9.1.1.1)

VXU_V04 Unsolicited Vaccination Update (4.A.6)

Links to Other/Further HL7 Information

generated: Jul 06, 2024 (FO)

Health Level Seven, Int. (HQ)

HL7 Germany
HL7 Europe

Frank Oemig's HL7 Site
(Infos about the database)

HL7-Experts Network